Jazz Pharmaceuticals is a biopharmaceutical company that specializes in the development and commercialization of medicines for patients with serious diseases. The company is focused on developing innovative products that address unmet medical needs in the areas of sleep and hematology/oncology.

Jazz Pharmaceuticals was founded in 2003 and is headquartered in Dublin, Ireland, with additional offices in the United States and Europe. The company has a diverse portfolio of products, including medicines for the treatment of narcolepsy, leukemia, lymphoma, and multiple myeloma.

Jazz Pharmaceuticals is committed to improving patient outcomes through scientific innovation, and the company invests heavily in research and development to identify and develop new treatments for serious diseases. The company also partners with academic institutions, patient advocacy groups, and other organizations to advance research and education in the areas of sleep and hematology/oncology.

Jazz Pharmaceuticals is dedicated to operating with integrity and transparency, and the company’s core values include innovation, teamwork, accountability, and integrity. The company strives to foster a culture of inclusion and diversity, and is committed to creating a workplace where all employees can thrive and make a meaningful impact on patient care.